<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-61599</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Plasma phytosterols: markers of a healthy diet and a lower cardiometabolic risk in the Spanish EPIC population study</dc:title>
<dc:description xml:lang="en">Introduction. Increased plasma phytosterols, which reflect increased cholesterol absorption, have been related to an increased cardiovascular risk. However, the metabolic syndrome (MetS), a cluster of risk factors that carries a high risk for cardiovascular diseases, has been associated with increased cholesterol synthesis and reduced cholesterol absorption, which translate into lower plasma phytosterol levels. In this study we investigated the relationships between plasma and dietary phytosterols and cardiovascular risk factors, including the components of MetS. Methods and results. In a cross-sectional study, we measured phytosterol intake and cholesterol-adjusted plasma non-cholesterol sterol levels in 592 healthy subjects of the Spanish EPIC (European Prospective Investigation into Cancer and Nutrition) cohort who were phenotyped for cardiovascular risk factors, including MetS constituents. Phytosterol intake, which reflects healthy food choices, and the HDL-cholesterol level increased and adiposity measures, cholesterol/HDL ratios, and glucose levels, triglycerides and lathosterol, a cholesterol synthesis marker, decreased across tertiles of plasma sitosterol-to-cholesterol ratios (P&lt;0.05; all). Results were inverse for plasma lathosterol. The ApoE genotype was unrelated to plasma non-cholesterol sterol tertiles. The multivariable-adjusted odds ratios (OR) for the MetS and its components across the lowest to the highest plasma sitosterol tertile ranged between 0.23 and 0.42 (P&lt;0.05; all). The OR for the same variables across respective lathosterol tertiles ranged between 1.99 and 3.00 (P&lt;0.05; all). Conclusions. The MetS is associated with increased plasma lathosterol, a cholesterol synthesis marker, and decreased plasma sitosterol, a joint marker of cholesterol absorption and a healthy diet. Thus, elevated plasma phytosterol concentrations are related to a lower cardiometabolic risk (AU)</dc:description>
<dc:creator>Moreno-Iribas, Concepción</dc:creator>
<dc:creator>Sánchez, M. José</dc:creator>
<dc:creator>Corella , Dolores</dc:creator>
<dc:creator>Ros, Emilio</dc:creator>
<dc:creator>Cofán, Montserrat</dc:creator>
<dc:creator>Navarro, Carmen</dc:creator>
<dc:creator>Larrañaga, Nerea</dc:creator>
<dc:creator>Escurriol, Verónica</dc:creator>
<dc:creator>Quirós, José Ramón</dc:creator>
<dc:creator>González, Carlos A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. Las concentraciones elevadas de fitoesteroles plasmáticos, que reflejan una mayor absorción intestinal de colesterol se han relacionado con un aumento del riesgo cardiovascular. Sin embargo, una situación de riesgo alto, el síndrome metabólico (SM), se asocia a un aumento de la síntesis y una disminución de la absorción de colesterol y, por tanto, a una menor fitoesterolemia. En este estudio hemos investigado la relación entre los fitoesteroles del plasma y la dieta y la presencia de factores de riesgo cardiovascular, incluidos los componentes del SM. Métodos y resultados. En un estudio transversal, se evaluaron la ingesta de fitoesteroles y concentraciones plasmáticas de esteroles nocolesterol ajustadas por colesterol en 592 individuos sanos de la cohorte española del estudio EPIC (European Prospective Investigation into Cancer and Nutrition) fenotipados para factores de riesgo cardiovascular, incluidas las variables del SM. La ingesta de fitoesteroles, que se asoció a alimentos saludables, y el colesterol unido a lipoproteínas de alta densidad (HDL) aumentaron, y las medidas de adiposidad, cociente colesterol/ HDL y concentraciones de glucosa, triglicéridos y latosterol, un precursor del colesterol, disminuyeron con los terciles de sitosterol plasmático ajustado por colesterol (p &lt; 0,05; todos). Los resultados para latosterol fueron opuestos a los de sitosterol. El genotipo de la apolipoproteína E no se relacionó con los terciles de esteroles no-colesterol del plasma. Las odds ratio (OR) ajustadas de ser portador de un SM o sus componentes para el tercil superior de sitosterol plasmático comparado con el inferior oscilaron entre 0,23 y 0,42 (p &lt; 0,05; todas). Las OR de las mismas variables para los terciles respectivos de latosterol variaron entre 1,99 y 3,00 (p &lt; 0,05; todas) (..) (AU)</dc:description>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);21(3): 106-114, mayo-jun. 2009. tab, graf</dc:source>
<dc:identifier>ibc-61599</dc:identifier>
<dc:title xml:lang="es">Fitoesteroles plasmáticos: marcadores de una dieta saludable y un riesgo cardiometabólico menor en la población española del estudio EPIC</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d32738^s22002</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d36032^s22032</dc:subject>
<dc:subject>^d2359^s22032</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d11272^s22062</dc:subject>
<dc:subject>^d28596</dc:subject>
<dc:subject>^d7117^s22032</dc:subject>
<dc:type>article</dc:type>
<dc:date>200906</dc:date>
</metadata>
</record>
</ibecs-document>
